GlaxoSmithKline Links With Top Labs On "Big Data" Drug Project

GlaxoSmithKline is linking with two top bioscience centres on an open-access research project to tap into "big data" generated by gene research, in a move highlighting how drug companies are learning to share. The new public-private Centre for Therapeutic Target Validation (CTTV) is being created by GSK working alongside the Wellcome Trust Sanger Institute and the European Bioinformatics Institute, both of which are based in Cambridge, England. The three founders said on Thursday they hoped to attract interest from other companies and academic institutions over time.

Help employers find you! Check out all the jobs and post your resume.